Reutericyclin

Overview

Reutericyclin (Reutericycline) is an orally active antibacterial and anti-obesity agent that selectively inhibits Gram-positive bacteria. By selectively dissipating transmembrane potential, Reutericyclin exerts non-lytic bactericidal or bacteriostatic activity against pathogens such as Clostridium difficile and Staphylococcus aureus , and rapidly kills vegetative cells and spores of Clostridium difficile . Reutericyclin possesses favorable properties including resistance to enzymatic hydrolysis, iron-chelating function, and poor absorption by colonic epithelium. Reutericyclin not only eradicates staphylococcal biofilms and inhibits drug-resistant strains, but also counteracts Risperidone ( HY-11018 )-induced weight gain by inducing changes in gut microbiota composition and restoring energy utilization efficiency. Reutericyclin can be used in research related to Clostridium difficile infection , Risperidone -induced weight gain, and staphylococcal superficial skin infections.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Lipid Metabolism | Products > Disease Areas > Bacterial Infection | Products > Disease Areas > Obesity | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Bacterial

Product Information

• Catalog No.: HY-103249
• CAS No.: 303957-69-9
• Molecular Formula: C20H31NO4
• Molecular Weight: 349.46
• Purity: 98.08%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Solubility: 2.5 mg/mL (7.15 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source